InvestorsHub Logo

maumar

11/29/21 3:27 PM

#240509 RE: DewDiligence #240505

DewDiligence

09/21/22 12:15 PM

#243896 RE: DewDiligence #240505

FDA approves FENC’s Pedmark for cisplatin-induced hearing loss in children with non-metastatic cancer:

https://finance.yahoo.com/news/fennec-pharmaceuticals-announces-fda-approval-110000297.html

This was the third FDA review cycle for FENC following two rejections for CMC problems.